Whilst the association between atrial fibrillation (AF) and thromboembolism is well
recognised, this risk is not homogeneous. Numerous clinical and echocardiographic factors …

Background: In 1995, atrial fibrillation (AF) was estimated to affect 2.2 million people in the
United States. After the age of 75 years (the median age for onset of AF),~ 60% of people …

Background The key drivers of symptom severity and health-related quality of life (hr-QOL) in
patients with atrial fibrillation (AF) remain unclear. We aimed to determine the relative …

Background: When presenting for atrial fibrillation (AF) ablation, women, compared with
men, tend to have more nonpulmonary vein triggers and advanced atrial disease. Whether …

Background Recent improvements in atrial fibrillation diagnosis and management have
prompted the initiation of various registries, predominantly to assess adherence to new …

Background Atrial fibrillation (AF) is a stronger risk factor for cardiovascular disease in
women than men. We assessed whether there are sex differences in the effects of 43 …

Aims In patients with non-valvular atrial fibrillation (NVAF), it is uncertain whether the higher
risk of ischaemic stroke in women reported in some studies is due to residual confounding …

Background Atrial fibrillation (AF) affects around 6 million Americans. AF management
involves pharmacologic therapy and/or interventional procedures to control rate and rhythm …

Objective Older, relatively small studies identified female sex as a risk factor for adverse
events after catheter ablation for atrial fibrillation (AF). We aimed to assess contemporary …

The prevalence of atrial fibrillation (AF) increases with age. As the population ages, the
burden of AF increases. AF is associated with an increased incidence of mortality, stroke …